In recent years, semaglutide has emerged as a breakthrough medication in the treatment of type 2 diabetes, obesity, and even heart health. This injectable medication belongs to the GLP-1 receptor agonists class, which works by mimicking the glucagon-like peptide-1 (GLP-1) hormone that plays a significant role in blood sugar control, https://zanderfkosx.ka-blogs.com/84354061/semaglutide-a-breakthrough-in-diabetes-weight-loss-and-cardiovascular-care